New research claims sufficiency of vitamin D reduces COVID-19 severity

New research claims sufficiency of vitamin D reduces COVID-19 severity

Published: Just now By Nikita Chaurasia

According to a recent study, COVID-19 patients having sufficient levels of vitamin D, with at least 30 ng/mL of 25-hydroxyvitamin D in their blood, are less likely to witness severe clinical outcomes and deaths. The stu....

Amazon adds indoor surveillance drone to security solutions portfolio

  This is the next big launch after the announcement of car security devices Indoor drone will offer video surveillance in places devoid of static cameras U.S.-based multinational technology giant, Amazon.com Inc. along with Ring....

JPMorgan to move USD 234 billion worth assets to Germany before Brexit

  JPMorgan indicated plans to expand its hub in Paris by reassigning services based in London post Brexit The bank plans on completing the migration of its assets to the Frankfurt subsidiary by the end of 2020 As per reliable sou....

Nike plans to exit brick & mortar stores, records mega returns online

U.S.-based multinational sports apparel firm, Nike Inc., has reportedly revealed a significant upturn in their digital sales amid the COVID-19 pandemic, recording a revenue of USD 10.6 billion. Sources close to the matter claim that the com....

Experts find druggable pocket in COVID-19, could lead to new antivirals

An international team of scientists, which was led by the University of Bristol, has reportedly discovered a druggable pocket in SARS-CoV-2 (coronavirus) Spike protein which can potentially be utilized to prevent the virus from affecting hu....

Baemin introduces next-generation robot for outdoor delivery services

Korean online food delivery service provider Baemin, has recently launched the new version of its next-gen delivery robot Dilly Drive. According to credible sources, the robot will offer significantly enhanced functionality and performance....

Breast cancer: New treatment claims to reduce recurrence risk by 25%

  The research comprised of patients with increased cellular proliferation and larger tumor size monarchE trials were funded by Eli Lilly and Co. and led by Royal Marsden NHS Foundation Trust Reportedly, the phase three monarchE ....